Mandelia Ashish (CIK 1782805) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-01-06). Recent activity: Sell MRSN (2,300 shares), Buy MRSN (4,519 shares), Buy MRSN (4,166 shares), Sell MRSN (3,554 shares), Buy MRSN (4,783 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-06 | Mersana Therapeutics, Inc. (MRSN) | VP, Chief Accounting Officer | Sell | 2,300 | $0 |
| 2025-01-17 | Mersana Therapeutics, Inc. (MRSN) | VP, Chief Accounting Officer | Buy | 4,519 | $0 |
| 2025-01-17 | Mersana Therapeutics, Inc. (MRSN) | VP, Chief Accounting Officer | Buy | 4,166 | $0 |
| 2025-01-17 | Mersana Therapeutics, Inc. (MRSN) | VP, Chief Accounting Officer | Sell | 3,554 | $2,061 |
| 2025-01-16 | Mersana Therapeutics, Inc. (MRSN) | VP, Chief Accounting Officer | Buy | 4,783 | $0 |
| 2025-01-16 | Mersana Therapeutics, Inc. (MRSN) | VP, Chief Accounting Officer | Sell | 1,791 | $1,128 |
| 2025-01-15 | Mersana Therapeutics, Inc. (MRSN) | VP, Chief Accounting Officer | Buy | 2,646 | $0 |
| 2025-01-15 | Mersana Therapeutics, Inc. (MRSN) | VP, Chief Accounting Officer | Sell | 1,007 | $665 |
Source: SEC Form 4 filings · as of 2026-01-06